Brain Insulin Resistance Biomarker May Aid in Alzheimer’s Diagnosis

blood test
blood test
A neuronal protein that plays a key role in insulin signaling in the brain may help predict Alzheimer's disease as many as 10 years before clinical symptoms.

A novel biomarker of brain insulin resistance defective in Alzheimer’s and detectable in blood shows promise for early preclinical diagnosis.

The protein, insulin receptor substrate-1 (IRS-1), plays a key role in insulin signaling in the brain. Brain insulin resistance occurs in AD even in the absence of peripheral insulin resistance, but until now, no brain biomarker of brain insulin resistance has been discovered.

READ FULL ARTICLE Curated publisher From Med Scape